Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 23/2003

01-12-2003 | Erratum

Erratum to: Tadalafil

Authors: Monique P. Curran, Gillian M. Keating

Published in: Drugs | Issue 23/2003

Login to get access

Excerpt

Vol 63, No. 20, 2003, page 2205: In the fourth bullet point of the Period of Responsiveness section, the first sentence should read “…the percentage of successful intercourse attempts after a single dose of tadalafil 20mg (measured by SEP-Q3) was 59% in the first 30 minutes…” …
Metadata
Title
Erratum to: Tadalafil
Authors
Monique P. Curran
Gillian M. Keating
Publication date
01-12-2003
Publisher
Springer International Publishing
Published in
Drugs / Issue 23/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200363230-00011

Other articles of this Issue 23/2003

Drugs 23/2003 Go to the issue

Adis Drug Profile

Azelnidipine

Adis Drug Profile

Azelnidipine

Adis Drug Evaluation

Combined Hepatitis A and B Vaccines

Adis Drug Evaluation

Levosimendan

Adis Drug Evaluation

Vardenafil

Review Article

CNS Involvement in Overactive Bladder